Efficacy of anakinra in bone: Comparison to other biologics

Advances in Therapy

Volumn 19, Issue 1, 2002, Pages 27-39

  Paget, Stephen A ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Biologics; Interleukin 1; Rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1; LEFLUNOMIDE; METHOTREXATE; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE RADIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; EROSION; HUMAN; JOINT CAVITY; LONG TERM CARE; MEDLINE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY;

EID: 0036232074     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850016     Document Type: Article

References (33)

1. Long-term outcomes in rheumatoid arthritis
2. Generalised bone loss in patients with early rheumatoid arthritis
3. Osteoporosis in rheumatoid arthritis: Effects of disease activity
4. Fractures after rheumatoid arthritis. A population-based study
5. Risk of vertebral fracture in women with rheumatoid arthritis
6. The effect of glucocorticoids on joint destruction in rheumatoid arthritis
7. Quantitative analysis of hand radiographs in rheumatoid arthritis: Time course of radiographic changes, relation to joint examination measures, and comparison of different scoring methods
8. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease
9. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: A controlled magnetic resonance imaging study
10. Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: One year follow up of patients with early arthritis
11. The links between joint damage and disability in rheumatoid arthritis
12. Rheumatoid arthritis: Pathophysiology and implications for therapy
13. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis
14. The role of interleukin-1 in disease
15. Bone loss: Factors that regulate osteoclast differentiation: An update
16. Pathogenesis of bone erosions in rheumatoid arthritis
17. Inhibitory cytokines and cytokine inhibitors
18. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis
19. Role of tumour necrosis factor α in experimental arthritis: Separate activity of interleukin 1β in chronicity and cartilage destruction
20. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
21. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
22. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial
23. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
24. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
25. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films
26. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: Correlation of radiologic, clinical and laboratory abnormalities
27. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs
28. Biannual radiographic assessment of hands and feet in the three-year prospective followup of patients with early rheumatoid arthritis
29. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of Genant and Larsen scores
30. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
31. Infliximab and methotrexate in the treatment of rheumatoid arthritis
32. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis